Hans Christian Diener

TL;DR: Fast reperfusion leads to improved functional outcome among patients with acute stroke treated with stent retrievers and detailed attention to workflow with iterative feedback and aggressive time goals may have contributed to efficient workflow environments.

TL;DR: The hypothesis is put forward that successful therapy of AF and its associated complications will require comprehensive therapy, and that a combination of management of underlying and concomitant conditions, early and comprehensive rhythm control therapy, adequate control of ventricular rate and cardiac function, and continuous therapy to prevent AF-associated complications are needed.

TL;DR: Empirical observations suggest that AF is still associated with a doubling of mortality, even after adjustment for confounders, and this observation from the last millennium appears to continue into current randomized trials in AF patients.

TL;DR: The GLORIA-AF is a large, international, observational registry involving patients with newly diagnosed nonvalvular AF at risk for stroke, enrolling up to 56,000 patients in nearly 50 countries and will add data from clinical practice to those from randomized trials to expand knowledge of antithrombotic treatment in patients with AF.